Precious Cells buys stem cell storage tech firm citing therapies as driver
UK stem cell storage firm Precious Cells BioBank (PCB) has bought tech company Pharmacells Group in a deal it says will accelerate its growth in the biologics sector.
UK stem cell storage firm Precious Cells BioBank (PCB) has bought tech company Pharmacells Group in a deal it says will accelerate its growth in the biologics sector.
While the overall bioscience industry has seen 7.4% jobs growth between 2001 and 2012, the sector encompassing CROs and other research, testing and medical labs has grown by more than 28%, according to a new report from industry group BIO and Battelle.
Doctors’ attitudes and brand awareness are major drivers behind the success or failure of biosimilars, an expert has told BioPharma-Reporter.com.